Foresite Software Systems Inc. will be hosting a complimentary webinar, the latest in a series of educational seminars for the manufacturing industry.

As of December 2012, the EU REACH regulation SVHC list was expanded to 138 substances that must now be declared to upstream customers and regulators, and the new substance and labeling requirements under the REACH regulation's substance and mixture provisions have now taken effect. These regulatory disclosure obligations will send ripple effects through industry, which will increase with the approach of the June 1, 2013, registration deadline for pre-registered substances being imported into the EU.

In an effort to continue to support industry in managing the ever expanding requirements of environmental regulation, the Foresite webinar will discuss the emerging REACH requirements and the best practices for managing the associated obligations including:

• An outline and recap of the new obligations under the REACH and CLP regulatory framework.
• A discussion and briefing concerning the pending impacts REACH will impose on industry in 2013.
• A briefing concerning how to coordinate building an inventory of full material declarations that can satisfy the disclosure requirements of the REACH regulation.
• A demonstration of what a functional system of record should look like and how it should be used for compliance purposes.

The webinar will be presented by Travis Miller, vice president of Regulatory Services, and Graham Margetson, president of Sales and Marketing for Foresite Compliance. Travis and Graham are recognized experts in environmental regulatory compliance business processes, and have advised many of the largest blue chip companies on how to develop sound, defensible regulatory compliance processes. Those interested in registering for the free Webinar may do so by visiting www.foresitecloud.com and clicking on the Webinar Tab.

Lance Allison , CEO of Foresite, stated "As this deadline approaches, the ability for manufacturers, distributors and retailers to identify, maintain and disclose the exact substance concentration within product and to maintain clear audit trails featuring source collateral documentation will be critical for compliance. Correspondingly, as the regulation matures, the resulting enforcement measures for non-compliance are anticipated to escalate."